|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net Income | |
| Adjustments to reconcile net income to net cash provided by operating activities: | |
| Vessel depreciation | |
| Amortization and write-off of deferred financing costs | |
| Offering costs expensed attributable to warrants treated as liability (Note 9,12) | |
| Debt Prepayment fees (Note 7, 12) | |
| Loss on derivative financial instruments | |
| (Increase)/Decrease in: | |
| Inventories | |
| Trade accounts receivable | |
| Prepayments and other | |
| Due from related parties | |
| Increase/(Decrease) in: | |
| Accounts payable | |
| Accrued liabilities | |
| Unearned revenue | |
| Net Cash provided by Operating Activities | |
| Cash Flows from Investing Activities: | |
| Advances for asset acquisitions and related deferred charges | |
| Net Cash used in Investing Activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from debt | |
| Net payments to Former Parent company | |
| Principal payments of debt | |
| Prepayment of debt | |
| Payment of financing costs | |
| Proceeds from related party debt | |
| Prepayment of related party debt | |
| Payment of debt Prepayment fees (Note 7, 12) | |
| Payment of debt Prepayment fees-related party (Note 7, 12) | |
| Proceeds from equity offerings, gross | |
| Equity issuance costs (Note 9) | |
| Net Cash (used in)/provided by Financing Activities | |
| Net increase/(decrease) in cash and cash equivalents and restricted cash | |
| Cash and cash equivalents and restricted cash at beginning of the year | |
| Cash and cash equivalents and restricted cash at end of the year | |
| Cash breakdown | |
| Cash and cash equivalents | |
| Restricted cash, current | |
| Restricted cash, non-current | |
| SUPPLEMENTAL CASH FLOW INFORMATION | |
| Finance fees included in Accounts payable/Accrued liabilities/Due to related parties | |
| Equity issuance costs included in Accounts payable/Accrued liabilities/Due to related part | |
| Interest paid |
Loading...
